Literature DB >> 9597019

Differences in prescription drug utilization and expenditures between Blacks and Whites in the Georgia Medicaid population.

R K Khandker1, L J Simoni-Wastila.   

Abstract

To address policy concerns regarding prescription drug access by vulnerable minority groups, we analyzed prescription drug use and spending among black and white enrollees in the Georgia Medicaid program. Using a two-part model estimating use and level of use of any prescription drugs, the study examined black/white differences controlling for age, sex, and Medicaid eligibility characteristics. Results showed black enrollees were significantly less likely to use any prescription drugs and received significantly fewer prescriptions than white enrollees. After adjustment, the black/white difference for children was 43%, with black children using 2.7 fewer prescriptions relative to white children. Patterns of use were similar for adults and the elderly, with black adults using 4.9 fewer prescriptions, and black elders using 6.3 fewer prescriptions, than their white peers. Spending rates per full-year enrollee were similar to utilization patterns and maintained the black/white differential. White Medicaid enrollees had higher use and spending than black enrollees across most high-volume therapeutic drug categories. The study explores several possible explanations for these differences.

Entities:  

Mesh:

Year:  1998        PMID: 9597019

Source DB:  PubMed          Journal:  Inquiry        ISSN: 0046-9580            Impact factor:   1.730


  7 in total

1.  Assessing implementation of cultural competency content in the curricula of colleges of pharmacy in the United States and Canada.

Authors:  Esther Moraa Onyoni; Timothy J Ives
Journal:  Am J Pharm Educ       Date:  2007-04-15       Impact factor: 2.047

2.  Utilizing new prescription drugs: disparities among non-Hispanic whites, non-Hispanic blacks, and Hispanic whites.

Authors:  Junling Wang; Ilene H Zuckerman; Nancy A Miller; Fadia T Shaya; Jason M Noel; C Daniel Mullins
Journal:  Health Serv Res       Date:  2007-08       Impact factor: 3.402

3.  Racial and ethnic disparities in meeting Part D MTM eligibility criteria among the non-Medicare population.

Authors:  Junling Wang; Lawrence M Brown; Song Hee Hong
Journal:  J Am Pharm Assoc (2003)       Date:  2012 Sep-Oct

4.  Disparities in the appropriateness of medication use: Analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) population-based cohort study.

Authors:  Motiur Rahman; George Howard; Jingjing Qian; Kimberly Garza; Ash Abebe; Richard Hansen
Journal:  Res Social Adm Pharm       Date:  2020-02-20

5.  Age and sex patterns of drug prescribing in a defined American population.

Authors:  Wenjun Zhong; Hilal Maradit-Kremers; Jennifer L St Sauver; Barbara P Yawn; Jon O Ebbert; Véronique L Roger; Debra J Jacobson; Michaela E McGree; Scott M Brue; Walter A Rocca
Journal:  Mayo Clin Proc       Date:  2013-06-19       Impact factor: 7.616

6.  Benzodiazepine use and expenditures for Medicare beneficiaries and the implications of Medicare Part D exclusions.

Authors:  Hui-wen Keri Yang; Linda Simoni-Wastila; Ilene H Zuckerman; Bruce Stuart
Journal:  Psychiatr Serv       Date:  2008-04       Impact factor: 3.084

Review 7.  Disparity implications of the Medicare medication therapy management eligibility criteria: a literature review.

Authors:  Kiraat D Munshi; Ya-Chen T Shih; Lawrence M Brown; Samuel Dagogo-Jack; Jim Y Wan; Junling Wang
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2013-04       Impact factor: 2.217

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.